Login / Signup

Efficacy of Drpitor1a, a Dynamin-Related Protein 1 inhibitor, in Pulmonary Arterial Hypertension.

Danchen WuRoss D Jansen-van VuurenAsish DasguptaRuaa Al-QazaziKuang-Hueih ChenAshley MartinJeffrey D MewburnElahe AlizadehPatricia Daniele Azevedo LimaOliver JonesPierce ColpmanNolan M BreaultIsaac M EmonLuka JedlovčnikYuan Yuan ZhaoMichael WellsGopinath SutendraStephen L Archer
Published in: bioRxiv : the preprint server for biology (2023)
Drpitor1a inhibits Drp1 GTPase, reduces mitochondrial fission, and inhibits cell proliferation in PAH hPASMC. Drpitor1a caused no toxicity in MCT-PAH and had no significant effect on normal rats or hPASMCs. Drpitor1a is a potential PAH therapeutic which displays an interesting therapeutic sexual dimorphism.
Keyphrases
  • pulmonary arterial hypertension
  • cell proliferation
  • polycyclic aromatic hydrocarbons
  • pulmonary artery
  • pulmonary hypertension
  • oxidative stress
  • mental health
  • cell cycle
  • coronary artery
  • risk assessment
  • human health